Correction to: Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders (Journal of Neuroimmune Pharmacology, (2019), 14, 3, (391-400), 10.1007/s11481-019-09859-w)

Michael T. Nedelcovych, Boe Hyun Kim, Xiaolei Zhu, Lyndah E. Lovell, Arena A. Manning, Jennifer Kelschenbach, Eran Hadas, Wei Chao, Eva Prchalová, Ranjeet P. Dash, Ying Wu, Jesse Alt, Ajit G. Thomas, Rana Rais, Atsushi Kamiya, David J. Volsky, Barbara S. Slusher

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original version of this article unfortunately contained a mistake. For David Volsky’s 2nd award, it is listed as R01MH105145 but the correct grant number should be R01MH104145. The original article has been corrected.

Original languageEnglish (US)
JournalJournal of Neuroimmune Pharmacology
DOIs
StateAccepted/In press - 2021

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Immunology and Allergy
  • Immunology
  • Pharmacology

Fingerprint Dive into the research topics of 'Correction to: Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders (Journal of Neuroimmune Pharmacology, (2019), 14, 3, (391-400), 10.1007/s11481-019-09859-w)'. Together they form a unique fingerprint.

Cite this